Constant Therapy, Inc.

Constant Therapy, Inc. is a digital health company that specializes in providing innovative at-home speech and cognitive therapy solutions for adults recovering from neurological conditions. Constant Therapy, Inc. was founded in 2012 and is headquartered in Newton, US.

The company focuses on developing digital therapy solutions. In May 2017, Digital Health Corp acquired Constant Therapy, Inc. for an undisclosed amount. The company has raised USD 2.

00 mn in total funding, with the latest round being a Series A led by Golden Seeds, which occurred on May 31, 2017. The founders of the company include Ehsan Dadgar-Kiani, Mahendra Advani, Swathi Kiran, and Veera Anantha, who currently serves as CEO. Constant Therapy offers a comprehensive digital platform designed for at-home speech and cognitive therapy, specifically targeting adults recovering from neurological conditions such as strokes, traumatic brain injuries, aphasia, dementia, and Parkinson's disease. The core product, Constant Therapy, is an evidence-based application available on smartphones, tablets, and Chromebooks, providing users with a vast library of exercises that adapt to individual progress through the proprietary NeuroPerformance Engine (NPE).

This technology enables personalized therapy sessions that users can access anytime and anywhere. The platform also features a dedicated application for clinicians, allowing speech therapists to manage and customize therapy programs for their clients. The products are available in multiple language variants, including English (US), English (India), and Spanish (US), catering to diverse markets across North America and India. Constant Therapy operates primarily on a subscription model, where users can access its services through monthly or annual billing plans.

Revenue is generated through individual subscriptions, enabling users to access a wide range of evidence-based exercises and real-time feedback. Specific pricing plans are tailored towards both patients seeking therapy and clinicians, thus facilitating ongoing support for individuals with speech and cognitive challenges. The recurring revenue model is built on the continuous engagement of users with the platform, ensuring consistent service delivery and client retention. Constant Therapy aims to leverage its recent funding to enhance its digital platform and introduce new products designed for therapeutic purposes.

Plans for expanding into new markets include targeting additional regions within North America and potentially entering the European market by 2025. The recent funding will support these initiatives, enabling the development of new features and enhancements to the existing therapy programs.